Experts recommend metastatic spinal injury treatmentRSS Feed

Patients that suffer spinal injury as a result of metastatic cancer could soon benefit from a new relieving treatment.

The procedure involves placing a small balloon into fractured spinal vertebrae, known as balloon kyphoplasty. It has been recommended by researchers at the recent Congress of the European Society for Medical Oncology in Milan.

Patients that suffer from multiple myeloma, particularly where cancer has spread beyond the initial tumor site, often suffer compression fractures in their spine.

Professor Leonard Bastian explained: "Balloon kyphoplasty offers quick pain relief; restores patient activity and mobility and it gives an important improvement of quality of life.

"It may be the right treatment option for vertebral compression fractures if conventional pain medication has not been effective or has too many side-effects."

Meanwhile, efforts to introduce a new therapeutic spinal injury treatment to the market moved a step closer to fulfilment earlier this week, when Geron Corporation enrolled its first patient onto a new clinical trial.

News from Serious Law, specialist spinal injury claim solicitors

Posted by Paul Breen

Spinal fracture diagnosis 'may be lagging'

13 October 2010

Certain types of spinal injury are being neglected by health professionals, researchers claim.Concerns were aired at the International Osteoporosis Foundation (IOF) press conference in Brussels this week,...

Read More...

Spinal cord injury stem cell the human trials begin

12 October 2010

A spinal cord injury patient in the US has become the first ever to be injected with human embryonic stem cells in a federally-approved trial.The patient is enrolled at the spinal cord and brain injury...

Read More...

Swedish stem cell researchers make spinal cord injury breakthrough

11 October 2010

Spinal cord injury patients are a little closer to the prospect of stem cells being used to repair damaged tissue after scientists in Sweden made a breakthrough with mice.Researchers at the Karolinska...

Read More...